Frontlight ResearchEarly access
Trial site
Yinchuan
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy2 trials
- Multiple sclerosis2 trials
- Sjögren's disease2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Lupus (SLE)1 trial
- Migraine1 trial
- Psoriasis1 trial
- Stroke1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals10 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026